Berenson Acquisition Corp. I

BACA

時価総額 $8451万

New York, New York--(Newsfile Corp. - September 25, 2024) - Berenson Acquisition Corp. I, (NYSE American: BACA) a special purpose acquisition company (" BACA " or the " Company "), announced that it will not complete its initial business combination by September 30, 2024, and therefore, the Company will dissolve and liquidate. The liquidation of the Trust Account is expected to occur on October 16th, 2024.

NEW YORK , July 18, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Berenson Acquisition Corp. I (NYSE American: BACA)'s  merger with Custom Health Inc. Under the proposed transaction, Custom Health will combine with Berenson and become a publicly-listed entity trading on the NYSE under its existing name. The proposed transaction implies a $185 million pre-money equity value for Custom Health.

New York, New York--(Newsfile Corp. - June 3, 2024) - Berenson Acquisition Corp. I (NYSE American: BACA) (the "Company") announced today that, as previously disclosed in its annual report on Form 10-K for the fiscal year ended December 31, 2023, which was filed on May 31, 2024 with the U.S. Securities and Exchange Commission, the audited financial statements contained an audit opinion from its independent registered public accounting firm that included an explanatory paragraph related to the Company's ability to continue as a going concern. This announcement is made pursuant to NYSE American LLC Company Guide Sections 401(h) and 610(b), which require public announcement of the receipt of an audit opinion containing a going concern paragraph.

Reaffirms commitment to regaining compliance with the NYSE American continued listing standards New York, New York--(Newsfile Corp. - April 23, 2024) - On April 17, 2024, Berenson Acquisition Corp. I (NYSE American: BACA), a Delaware corporation (the "Company"), received an official notice of noncompliance (the "NYSE American Notice") from NYSE Regulation ("NYSE") stating that the Company is not in compliance with NYSE American continued listing standards (the "Filing Delinquency Notification") due to the failure to timely file the Company's Form 10-K for the year ended December 31, 2023 (the "Delinquent Report") by the filing due date of April 16, 2024 (the "Filing Delinquency"). The Company is now subject to the procedures and requirements set forth in Section 1007 of the NYSE American Company Guide (the "Company Guide").